Pro Share Advisors LLC Ironwood Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 38,937 shares of IRWD stock, worth $137,447. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,937
Previous 31,173 24.91%
Holding current value
$137,447
Previous $203,000 21.18%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$3.93 - $7.04 $30,512 - $54,658
7,764 Added 24.91%
38,937 $160,000
Q2 2024

Aug 13, 2024
SELL
$5.58 - $8.61 $43,021 - $66,383
-7,710 Reduced 19.83%
31,173 $203,000
Q1 2024

May 08, 2024
BUY
$8.32 - $15.45 $24,269 - $45,067
2,917 Added 8.11%
38,883 $338,000
Q4 2023

Feb 14, 2024
BUY
$8.79 - $11.51 $41,339 - $54,131
4,703 Added 15.04%
35,966 $411,000
Q3 2023

Nov 13, 2023
SELL
$8.25 - $11.35 $2,871 - $3,949
-348 Reduced 1.1%
31,263 $301,000
Q2 2023

Aug 10, 2023
BUY
$10.1 - $11.6 $12,069 - $13,862
1,195 Added 3.93%
31,611 $336,000
Q1 2023

May 11, 2023
SELL
$10.37 - $12.56 $38,887 - $47,100
-3,750 Reduced 10.98%
30,416 $319,000
Q4 2022

Feb 02, 2023
BUY
$9.9 - $12.43 $25,542 - $32,069
2,580 Added 8.17%
34,166 $423,000
Q3 2022

Nov 04, 2022
SELL
$10.14 - $12.38 $1,642 - $2,005
-162 Reduced 0.51%
31,586 $328,000
Q2 2022

Aug 01, 2022
SELL
$11.05 - $12.72 $135,450 - $155,921
-12,258 Reduced 27.86%
31,748 $367,000
Q1 2022

May 10, 2022
SELL
$10.61 - $12.88 $117,824 - $143,032
-11,105 Reduced 20.15%
44,006 $553,000
Q4 2021

Feb 08, 2022
BUY
$10.86 - $13.95 $18,375 - $23,603
1,692 Added 3.17%
55,111 $642,000
Q3 2021

Nov 12, 2021
SELL
$11.92 - $13.92 $159,394 - $186,138
-13,372 Reduced 20.02%
53,419 $698,000
Q2 2021

Aug 13, 2021
BUY
$10.16 - $13.11 $19,050 - $24,581
1,875 Added 2.89%
66,791 $860,000
Q1 2021

May 14, 2021
BUY
$9.04 - $11.86 $43,889 - $57,580
4,855 Added 8.08%
64,916 $726,000
Q4 2020

Feb 09, 2021
BUY
$9.05 - $12.2 $133,324 - $179,730
14,732 Added 32.5%
60,061 $684,000
Q3 2020

Nov 13, 2020
SELL
$8.99 - $10.74 $16,406 - $19,600
-1,825 Reduced 3.87%
45,329 $408,000
Q2 2020

Aug 03, 2020
BUY
$9.14 - $11.97 $150,151 - $196,643
16,428 Added 53.47%
47,154 $487,000
Q1 2020

May 15, 2020
SELL
$8.58 - $14.01 $206,100 - $336,534
-24,021 Reduced 43.88%
30,726 $310,000
Q4 2019

Feb 12, 2020
SELL
$8.22 - $14.0 $42,102 - $71,708
-5,122 Reduced 8.56%
54,747 $729,000
Q3 2019

Nov 12, 2019
SELL
$8.59 - $10.96 $3,942 - $5,030
-459 Reduced 0.76%
59,869 $514,000
Q2 2019

Aug 13, 2019
SELL
$9.8 - $12.89 $73,519 - $96,700
-7,502 Reduced 11.06%
60,328 $660,000
Q1 2019

May 15, 2019
BUY
$8.27 - $12.73 $45,972 - $70,766
5,559 Added 8.93%
67,830 $918,000
Q4 2018

Feb 14, 2019
SELL
$7.8 - $16.13 $89,177 - $184,414
-11,433 Reduced 15.51%
62,271 $645,000
Q3 2018

Nov 14, 2018
SELL
$14.31 - $17.65 $35,961 - $44,354
-2,513 Reduced 3.3%
73,704 $1.36 Million
Q2 2018

Aug 13, 2018
SELL
$11.83 - $16.2 $50,798 - $69,562
-4,294 Reduced 5.33%
76,217 $1.46 Million
Q1 2018

May 14, 2018
SELL
$11.13 - $13.63 $138,290 - $169,352
-12,425 Reduced 13.37%
80,511 $1.24 Million
Q4 2017

Feb 14, 2018
BUY
$12.16 - $14.58 $92,488 - $110,895
7,606 Added 8.91%
92,936 $1.39 Million
Q3 2017

Nov 13, 2017
BUY
$12.07 - $14.87 $55,703 - $68,625
4,615 Added 5.72%
85,330 $1.35 Million
Q2 2017

Aug 11, 2017
BUY
N/A
80,715
80,715 $1.52 Million

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email